πŸ‡ΊπŸ‡Έ FDA
Patent

US 10759721

Deuterated CFTR potentiators

granted A61PA61P11/12

Quick answer

US patent 10759721 (Deuterated CFTR potentiators) held by Vertex Pharmaceuticals (Europe) Limited expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals (Europe) Limited
Grant date
Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61P, A61P11/12